Main Article Content


The current study aimed to study some virulence factors and test the antibiotic susceptibility of some fungi isolated from different clinical sites. This study was conducted in the Postgraduate Studies Laboratory / College of Science - University of Kirkuk. (220) samples were collected from chronic wound infections for patients hospitalized in Kirkuk General Hospital and Azadi Teaching Hospital in the city of Kirkuk. Each group included (69) samples from bed sore patients and (62) Samples from surgical infections (58) samples from diabetic foot patients and (31) samples from burn patients in the period between September to November 2023. Three types of yeast were isolated and diagnosed: Candida albicans, Candida tropical, and Candida krusei, and the most frequent ones were It is the yeast C. albicans, with 28(50%), Candida tropical, 18(32%), and C. krusei, 10(18%). Regarding virulence factors, C. albicans yeast showed the ability to form germ tubes and chlamydial spores. Chlamydospore formation While C. krusei and C. tropicalis were able to form surface growth on SDB liquid medium, the types of yeast showed different colors by growing them on chromo agar, as C. albicans was light green and C. krusei was pink. Light while C. tropicalis yeast has a metallic blue color. Regarding the drug sensitivity test, the results showed that all types of yeast were sensitive to the antibiotic Nystatin, reaching the diameters of inhibition. As for Amphotericin, all types of yeast were sensitive to it, and it was the most effective antibiotic among all types, with a rate of 100%. On the other hand, it was observed that the types of yeast were 100% sensitive, with the exception of two isolates of the type C. krusei, which were resistant to the antibiotic Clotrimazole, and to the antibiotic Ketoconazole. All types showed sensitivity to this antibiotic, except for one isolate, the yeast C. krusei, which was resistant to this antibiotic.


C. albicans antibiotic susceptibility wounds virulence factors

Article Details

How to Cite
Mustafa, A. M., & Mohammed, S. H. (2024). STUDY SOME VIRULENCE FACTORS AND ANTIBIOTIC SUSCEPTIBILITY OF SOME CANDIDA SPP. ISOLATED FROM DIFFERENT CLINICAL SITES. Central Asian Journal of Medical and Natural Science, 5(1), 152-160.


  1. 1. Fonder, M. A., Lazarus, G. S., Cowan, D. A., Aronson-Cook, B., Kohli, A. R., & Mamelak, A. J. (2008). Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. Journal of the American Academy of Dermatology, 58(2), 185–206.
  2. 2. Rahim, K., Saleha, S., Zhu, X., Huo, L., Basit, A., & Franco, O. L. (2017). Bacterial contribution in chronicity of wounds. Microbial Ecology, 73, 710–721.
  3. 3. Ic, M.-C., Burgess, J. L., O’Neill, K. E., Strbo, N., & Pastar, I. (2020). Skin microbiota and its interplay with wound healing. American Journal of Clinical Dermatology, 21(Suppl 1), 36–43.
  4. 4. Hasan SA, Najati AM, Abass KS. (2019). Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasia J Biosci 13: 1045-1050
  5. 5. Hamad O F., Khallil I. B., Awatif S. J. (2015). Isolated and identification some skin fungi and study effect of Laser Nd:YAG on this fungi. Kirkuk Journal of Science. 10(4): 209-221
  6. 6. Mohammed P. L., Najat A. Z., Hero A. O. (2021). Detection of Salmonella, Shigella and Candida spp. in stool from diarrheal children and evaluation the heating effect on Salmonella phage in Kirkuk city. Tikrit
  7. Journal of Pure Science. Volume 26(4): 6-11
  8. 7. Nussbaum, S. R., Carter, M. J., Fife, C. E., DaVanzo, J., Haught, R., Nusgart, M., & Cartwright, D. (2018). An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value in Health, 21(1), 27–32.
  9. 8. Weller, C. D., Team, V., & Sussman, G. (2020a). First-line interactive wound dressing update: a comprehensive review of the evidence. Front Pharmacol. 2020; 11: 155.
  10. 9. Tipton, C. D., Wolcott, R. D., Sanford, N. E., Miller, C., Pathak, G., Silzer, T. K., Sun, J., Fleming, D., Rumbaugh, K. P., & Little, T. D. (2020). Patient genetics is linked to chronic wound microbiome composition and healing. PLoS Pathogens, 16(6), e1008511.
  11. 10. Dowd, S. E., Delton Hanson, J., Rees, E., Wolcott, R. D., Zischau, A. M., Sun, Y., White, J., Smith, D. M., Kennedy, J., & Jones, C. E. (2011). Survey of fungi and yeast in polymicrobial infections in chronic wounds. Journal of Wound Care, 20(1), 40–47.
  12. 11. Bansal, E., Garg, A., Bhatia, S., Attri, A. K., & Chander, J. (2008). Spectrum of microbial flora in diabetic foot ulcers. Indian Journal of Pathology and Microbiology, 51(2), 204.
  13. 13. Al-abide, N. M., Mezher, M. A., & Mahde Shugran, A. H. (2020). Identify the chemical content and biological efficacy of brassicaceae family and their effect on the growth of Candida albicans yeast isolated from various pathological infections. EurAsian Journal of Biosciences, 14(2).
  14. 14. Forbes, B. A., Sahm, D. F., & Weissfeld, A. S. (2007). Diagnostic microbiology. Mosby St Louis.
  15. 15. MacFaddin, J. F. (2000). Individual biochemical tests. Biochemical Tests for Identification of Medical Bacteria, 3, 27–439.
  16. 16. AL-Bajilan, A. M. (2016). Study of the inhibitory of Snake venom Macrovipra lantana against the Virulence factor of vaginal Candida spp. Doctoral thesis. Tikrit University Iraq, 133pp.
  17. 17. Byadarahally Raju, S., & Rajappa, S. (2011). Isolation and identification of Candida from the oral cavity. International Scholarly Research Notices, 2011.
  18. 18. Madhavan, P., Jamal, F., Chong, P. P., & Ng, K. P. (2011). Identification of local clinical Candida isolates using CHROMagar Candida TM as a primary identification method for various Candida species. Trop Biomed, 28, 269–274.
  19. 19. Ibraheem, R. S., & Abbas, B. A. (2015). Study on Candida species isolated from cows with molecular detection of some virulence gene. Bas. J. Vet. Res, 14(2), 31–43.
  20. 20. Ellis, D. H. (1994). Clinical mycology: The human opportunistic mycosis. Gillingham. Printers pty. Ltd. Australia. 166p.
  21. 21. AL-Maliki, R., & AL-Ani, Z. (2011). Antifungal resistance of Candida species isolated from Iraqi women infected with vulvovaginal Candidiasis. Al-Qadisiyah Medical Journal, 7(11), 117–127.
  22. 22. Al-Janabi, Muhammad Sami (2017) Inhibitory effectiveness of pomegranate peel extracts, Punica grantum, on some pathogenic yeasts and bacteria. Master’s thesis, College of Science, Tikrit University. 142 pages.
  23. 23. Salehei, Z., Seifi, Z., & Mahmoudabadi, A. (2012). Sensitivity of vaginal isolates of Candida to eight antifungal drugs isolated from Ahvaz, Iran. Jundishapur Journal of Microbiology, 5(4), 574–577.
  24. 24. Mahmoudabadi, A. Z., Zarrin, M., & Fard, M. B. (2012). Antifungal susceptibility of Candida species isolated from candidura. Jundishapur Journal of Microbiology, 6(1), 24–28.
  25. 25. Espinel-Ingroff, A. (2008). Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Revista Iberoamericana de Micología, 25(2), 101.
  26. 26. Mohammed, N. A. (2012). Detection of Candida spp. and other pathogens responsible for vulvovaginitis in women with contraceptive methods. MSc thesis. College of Science, University of Baghdad, Iraq.
  27. 27. Hussein, H. S., Dheeb, B. I., & Hamada, T. A. (2019). Studying the candida resistance and sensitivity for some antifungals. Journal of Biotechnology Research Center, 13(2), 26–34.
  28. 28. Mohammed B. A., Bare L. M., Mohammed B. K. (2019). Detection of Candida albicans in Females Urinary Tract Infection by using Microscopical and Cultural Methods of Urine Samples in Kirkuk City - Iraq. Journal of Global Pharma Technology. 11(05): 640-644
  29. 29. Awari, A. (2011). Species distribution and antifungal susceptibility profile of Candida isolated from urine samples. Int J App Basic Med Res, 18, 228–234.
  30. 30. Rajeevan, S., Thomas, M., & Appalaraju, B. (2016). Characterisation and antifungal susceptibility pattern of Candida species isolated from various clinical samples at a tertiary care Centre in South India. Indian J Microbiol Res, 3(1), 53–57.
  31. 31. Re III, V. Lo, Carbonari, D. M., Lewis, J. D., Forde, K. A., Goldberg, D. S., Reddy, K. R., Haynes, K., Roy, J. A., Sha, D., & Marks, A. R. (2016). Oral azole antifungal medications and risk of acute liver injury, overall and by chronic liver disease status. The American Journal of Medicine, 129(3), 283–291.
  32. 32. Lima, G. M. E., Nunes, M. de O., Chang, M. R., Tsujisaki, R. A. de S., Nunes, J. de O., Taira, C. L., Thomaz, D. Y., Negro, G. M. B. Del, Mendes, R. P., & Paniago, A. M. M. (2017). Identification and antifungal susceptibility of Candida species isolated from the urine of patients in a university hospital in Brazil. Revista Do Instituto de Medicina Tropical de São Paulo, 59.
  33. 33. Padmapriya, G. A. A., Amshavathani, S. K., & Percy, Q. (2015). Molecular confirmation of Candida species using self designed primers by PCR. International Journal of Current Microbiology and Applied Sciences, 4(5), 289–294.
  34. 34. Mohammed B. l, Kalil I. B. Thekra A. H. (2015). Prevalence of Vaginal Candidiasis among women and Diagnosis of Candida species from vaginal infection in Kirkuk city. Tikrit Journal of Pure Science. 20(4): 5-1